Literature DB >> 32419220

The role of self-monitoring metacognition sub-function and negative urgency related to binge severity.

Matteo Aloi1,2, Marianna Rania1,2, Elvira A Carbone1,2, Giuseppina Calabrò1,2, Mariarita Caroleo1,2, Antonino Carcione3, Giuseppe Nicolò3, Antonio Semerari3, Cristina Segura-Garcia1,4.   

Abstract

OBJECTIVE: This study aims to test a model where low self-monitoring (a sub-function of first-person domain of metacognition) and high negative urgency lead to a worsening of binge severity through the mediation of emotional dysregulation in patients with binge eating disorder (BED).
METHOD: Forty non-BED-obese and 46 BED-obese patients completed a battery of tests assessing metacognition and psychopathology. To test our hypothesized model, a structural equation model (SEM) using maximum likelihood estimation was conducted.
RESULTS: BED-obese patients had significantly higher scores in BES, UPPS-P Negative urgency, and DERS total score, and lower MSAS self-monitoring than non-BED-obese, while no differences emerged in the MSAS others-monitoring subscale. The structural model demonstrated very good fit indexes (χ2 = 1.377, df = 2; p = .502, CMIN/DF = 0.688, CFI = 1.000, RMSEA = 0.000, TLI = 1.047) and all paths were significant in the predicted directions.
CONCLUSIONS: These preliminary findings show that, low self-monitoring and high negative urgency lead BED-obese patients to express the worsening of binge severity through the mediation of emotional dysregulation. This knowledge may be helpful in the clinical practice to develop a tailor-made treatment. Accordingly, an approach through Metacognitive Interpersonal Therapy could be attempted in BED-obese patients with these characteristics. Highlights Patients with BED exhibited low self-monitoring and high negative urgency. Binge severity was mediated by high level of emotional dysregulation. Metacognitive Interpersonal Therapy may be useful for BED patients.
© 2020 John Wiley & Sons, Ltd and Eating Disorders Association.

Entities:  

Keywords:  binge eating disorder; binge severity; emotional dysregulation; metacognition; negative urgency

Year:  2020        PMID: 32419220     DOI: 10.1002/erv.2742

Source DB:  PubMed          Journal:  Eur Eat Disord Rev        ISSN: 1072-4133


  5 in total

1.  Impaired Metacognitive Differentiation, High Difficulty in Controlling Impulses and Non-acceptance of Emotions are Associated With the Severity of Gambling Disorder.

Authors:  Matteo Aloi; Claudia Riccelli; Francesco Piterà; Mariarita Notaro; Vittoria Curcio; Luigi Pullia; Carla Sorrentino; Maria Giulia Audino; Antonino Carcione; Cristina Segura-Garcia; Pasquale De Fazio
Journal:  J Gambl Stud       Date:  2022-01-08

2.  Metacognition and emotion regulation as treatment targets in binge eating disorder: a network analysis study.

Authors:  Matteo Aloi; Marianna Rania; Elvira Anna Carbone; Mariarita Caroleo; Giuseppina Calabrò; Paolo Zaffino; Giuseppe Nicolò; Antonino Carcione; Gianluca Lo Coco; Carlo Cosentino; Cristina Segura-Garcia
Journal:  J Eat Disord       Date:  2021-02-15

3.  Exploring Correlates of Loss of Control Eating in a Nonclinical Sample.

Authors:  Eva M Conceição; Célia S Moreira; Marta de Lourdes; Sofia Ramalho; Ana Rita Vaz
Journal:  Front Psychol       Date:  2022-02-11

4.  The Role of Emotion Regulation in Eating Disorders: A Network Meta-Analysis Approach.

Authors:  Jenni Leppanen; Dalia Brown; Hannah McLinden; Steven Williams; Kate Tchanturia
Journal:  Front Psychiatry       Date:  2022-02-23       Impact factor: 4.157

5.  The neural correlates of delay discounting in obesity and binge eating disorder.

Authors:  Romina Miranda-Olivos; Trevor Steward; Ignacio Martínez-Zalacaín; Gemma Mestre-Bach; Asier Juaneda-Seguí; Susana Jiménez-Murcia; José A Fernández-Formoso; Nuria Vilarrasa; Misericordia Veciana de Las Heras; Nuria Custal; Nuria Virgili; Rafael Lopez-Urdiales; José M Menchón; Roser Granero; Carles Soriano-Mas; Fernando Fernandez-Aranda
Journal:  J Behav Addict       Date:  2021-04-26       Impact factor: 6.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.